Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saye Khoo

Showing results (41-50 of 282) with videos related to

Pageof 29
Sort By:
The Journal of Antimicrobial Chemotherapy|October 14, 2017
Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modellingAdeniyi Olagunju, Alessandro Schipani, Oluseye Bolaji, et al.
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19Catia Marzolini, Fiona Marra, Alison Boyle, et al.
AIDS (London, England)|November 26, 2019
Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1-infected womanCornelia Feiterna-Sperling, Renate Krüger, Alieu Amara, et al.
Frontiers in Pharmacology|March 29, 2019
The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological AnalysisSulav Duwal, Daniel Seeler, Laura Dickinson, et al.
AIDS (London, England)|April 30, 2016
Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosingJoseph M Lewis, Eimear Railton, Andrew Riordan, et al.
Journal of the International AIDS Society|November 14, 2014
Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
AIDS (London, England)|December 20, 2015
Dosing antiretroviral medication when crossing time zones: a reviewJoseph M Lewis, Alain Volny-Anne, Catriona Waitt, et al.
Frontiers in Pharmacology|January 2, 2023
Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modellingSandra Grañana-Castillo, Maiara Camotti Montanha, Rachel Bearon, et al.
Pharmacogenetics and Genomics|May 20, 2016
Pregnancy affects nevirapine pharmacokinetics: evidence from a CYP2B6 genotype-guided observational studyAdeniyi Olagunju, Oluseye Bolaji, Megan Neary, et al.
Arthritis and Rheumatism|February 5, 2005
Drug efflux transporters in rheumatoid arthritis: comment on the article by KremerSamantha L Hider, Patrick Hoggard, Saye Khoo, et al.
Pageof 29

Showing results (41-50 of 282) with videos related to

Sort By:
Pageof 29
The Journal of Antimicrobial Chemotherapy|October 14, 2017
Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modellingAdeniyi Olagunju, Alessandro Schipani, Oluseye Bolaji, et al.
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19Catia Marzolini, Fiona Marra, Alison Boyle, et al.
AIDS (London, England)|November 26, 2019
Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1-infected womanCornelia Feiterna-Sperling, Renate Krüger, Alieu Amara, et al.
Frontiers in Pharmacology|March 29, 2019
The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological AnalysisSulav Duwal, Daniel Seeler, Laura Dickinson, et al.
AIDS (London, England)|April 30, 2016
Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosingJoseph M Lewis, Eimear Railton, Andrew Riordan, et al.
Journal of the International AIDS Society|November 14, 2014
Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
AIDS (London, England)|December 20, 2015
Dosing antiretroviral medication when crossing time zones: a reviewJoseph M Lewis, Alain Volny-Anne, Catriona Waitt, et al.
Frontiers in Pharmacology|January 2, 2023
Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modellingSandra Grañana-Castillo, Maiara Camotti Montanha, Rachel Bearon, et al.
Pharmacogenetics and Genomics|May 20, 2016
Pregnancy affects nevirapine pharmacokinetics: evidence from a CYP2B6 genotype-guided observational studyAdeniyi Olagunju, Oluseye Bolaji, Megan Neary, et al.
Arthritis and Rheumatism|February 5, 2005
Drug efflux transporters in rheumatoid arthritis: comment on the article by KremerSamantha L Hider, Patrick Hoggard, Saye Khoo, et al.
Pageof 29